ATE259817T1 - Herstellung von einem clavulansäuresalz - Google Patents

Herstellung von einem clavulansäuresalz

Info

Publication number
ATE259817T1
ATE259817T1 AT96939048T AT96939048T ATE259817T1 AT E259817 T1 ATE259817 T1 AT E259817T1 AT 96939048 T AT96939048 T AT 96939048T AT 96939048 T AT96939048 T AT 96939048T AT E259817 T1 ATE259817 T1 AT E259817T1
Authority
AT
Austria
Prior art keywords
clavulanic acid
pct
butanol
production
date
Prior art date
Application number
AT96939048T
Other languages
English (en)
Inventor
Helmut Wagner
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Application granted granted Critical
Publication of ATE259817T1 publication Critical patent/ATE259817T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/02—Preparation
    • C07D503/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D503/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96939048T 1995-11-15 1996-11-14 Herstellung von einem clavulansäuresalz ATE259817T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0186795A AT403375B (de) 1995-11-15 1995-11-15 Verfahren zur fällung von alkalisalzen der clavulansäure
PCT/EP1996/005015 WO1997018216A1 (en) 1995-11-15 1996-11-14 Production of a salt of clavulanic acid

Publications (1)

Publication Number Publication Date
ATE259817T1 true ATE259817T1 (de) 2004-03-15

Family

ID=3522721

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0186795A AT403375B (de) 1995-11-15 1995-11-15 Verfahren zur fällung von alkalisalzen der clavulansäure
AT96939048T ATE259817T1 (de) 1995-11-15 1996-11-14 Herstellung von einem clavulansäuresalz

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0186795A AT403375B (de) 1995-11-15 1995-11-15 Verfahren zur fällung von alkalisalzen der clavulansäure

Country Status (25)

Country Link
US (1) US6133441A (de)
EP (1) EP0874855B1 (de)
JP (1) JP4319252B2 (de)
KR (1) KR100537732B1 (de)
CN (1) CN1090636C (de)
AT (2) AT403375B (de)
AU (1) AU714017B2 (de)
BR (1) BR9611572A (de)
CA (1) CA2237763C (de)
CZ (1) CZ296567B6 (de)
DE (1) DE69631608T2 (de)
ES (1) ES2216073T3 (de)
HK (1) HK1016971A1 (de)
HU (1) HUP9903478A3 (de)
IL (1) IL124353A (de)
MX (1) MX9803887A (de)
NO (1) NO982107D0 (de)
NZ (1) NZ322485A (de)
PL (1) PL188634B1 (de)
RU (1) RU2179171C2 (de)
SI (1) SI0874855T1 (de)
SK (1) SK285138B6 (de)
TR (1) TR199800860T2 (de)
TW (1) TW427991B (de)
WO (1) WO1997018216A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
DE60108154T2 (de) * 2000-10-20 2005-12-22 Sandoz Ag Pharmazeutische Zubereitungen enthaltend Clavulansäure
US8883772B2 (en) * 2007-10-09 2014-11-11 Sopharmia, Inc. Broad spectrum beta-lactamase inhibitors
WO2010118361A1 (en) * 2009-04-09 2010-10-14 Sopharmia, Inc. Beta lactamase inhibitors
DK2968352T3 (da) 2013-03-12 2019-01-02 Gladius Pharmaceuticals Corp Derivatiserede 3-styryl-cephalosporiner
CN109535184B (zh) * 2017-09-21 2020-11-20 联邦制药(内蒙古)有限公司 一种克拉维酸叔辛胺制备克拉维酸钾的方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
US4144242A (en) * 1975-02-07 1979-03-13 Glaxo Laboratories Limited Process for the purification of clavulanic acid
GB2003863B (en) * 1977-09-01 1982-03-31 Beecham Group Ltd Chemical process
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
AU600655B2 (en) * 1984-10-27 1990-08-23 Beecham Group Plc Preparation of clavulanic acid and its salts and esters
GB8618888D0 (en) * 1986-08-01 1986-09-10 Davy Mckee Ltd Process
DK175709B1 (da) * 1987-01-29 2005-01-31 Beecham Group Plc Fremgangsmåde til fremstilling af kalium-clavulanat
US5679789A (en) * 1987-01-29 1997-10-21 Beecham Group, P.L.C. Pharmaceutical compositions comprising potassium clavulanate and methods of using them
ES2010143A6 (es) * 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
US5210296A (en) * 1990-11-19 1993-05-11 E. I. Du Pont De Nemours And Company Recovery of lactate esters and lactic acid from fermentation broth
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
GB9401969D0 (en) * 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
TR199700828T1 (xx) * 1995-02-25 1998-04-21 Spurcourt Limited .Klavulanik asit tuzlar�.
GB2298201B (en) * 1995-02-25 1997-05-28 Spurcourt Ltd Clavulanic acid salts
SI9500074A (en) * 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500134B (sl) * 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
KR100200242B1 (ko) * 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
GB9515809D0 (en) * 1995-08-02 1995-10-04 Smithkline Beecham Plc Process
SI9500265A1 (en) * 1995-08-28 1997-02-28 Lek Tovarna Farmacevtskih Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
ZA975198B (en) * 1996-06-13 1997-12-15 Smithkline Beecham Corp Improved process for preparing potassium clavulanate.
CN1238776A (zh) * 1996-11-11 1999-12-15 吉斯特-布罗卡迪斯有限公司 制备棒酸盐和酯的方法

Also Published As

Publication number Publication date
HUP9903478A3 (en) 2000-05-29
RU2179171C2 (ru) 2002-02-10
SI0874855T1 (en) 2004-06-30
NZ322485A (en) 2000-01-28
NO982107L (no) 1998-05-08
US6133441A (en) 2000-10-17
CN1090636C (zh) 2002-09-11
ATA186795A (de) 1997-06-15
EP0874855B1 (de) 2004-02-18
HK1016971A1 (en) 1999-11-12
BR9611572A (pt) 1999-03-30
AU7625096A (en) 1997-06-05
DE69631608D1 (de) 2004-03-25
SK285138B6 (sk) 2006-07-07
AT403375B (de) 1998-01-26
AU714017B2 (en) 1999-12-16
SK64098A3 (en) 1998-10-07
KR100537732B1 (ko) 2006-04-14
MX9803887A (es) 1998-09-30
CN1204337A (zh) 1999-01-06
CZ296567B6 (cs) 2006-04-12
JP4319252B2 (ja) 2009-08-26
TW427991B (en) 2001-04-01
CZ149198A3 (cs) 1998-08-12
PL326696A1 (en) 1998-10-26
PL188634B1 (pl) 2005-03-31
IL124353A0 (en) 1998-12-06
CA2237763A1 (en) 1997-05-22
EP0874855A1 (de) 1998-11-04
ES2216073T3 (es) 2004-10-16
WO1997018216A1 (en) 1997-05-22
HUP9903478A2 (hu) 2000-03-28
CA2237763C (en) 2008-05-06
JP2000500149A (ja) 2000-01-11
NO982107D0 (no) 1998-05-08
DE69631608T2 (de) 2004-12-23
IL124353A (en) 2005-06-19
KR19990067480A (ko) 1999-08-25
TR199800860T2 (xx) 2000-07-21

Similar Documents

Publication Publication Date Title
DE59402222D1 (de) Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
EA199800477A1 (ru) Производные хинолина
ATE202337T1 (de) Cyclopropylalkansäurederivate
ATE19870T1 (de) 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE259817T1 (de) Herstellung von einem clavulansäuresalz
ATE132861T1 (de) Derivate von hexahydroazepine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE69628002D1 (de) Herstellung von clavunalat-salzen
ATE36854T1 (de) Tetrahydrothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE111734T1 (de) Verfahren zur herstellung von direktkomprimierten, cephalosporansäure derivate enthaltendentabletten.
ATE21101T1 (de) N-iminopyridinium-betain-derivate, ihre herstellung und ihre verwendung als arzneimittel.
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
CA2092919A1 (en) Epoxysuccinamic acid derivatives
DE3269029D1 (en) Bis-hydroxymethyl carbonate bridged antibacterial agents
DE58907390D1 (de) Sulfonamide mit Tetrazolylrest, Verfahren zu ihrer Herstellung sowie Arzneimittel.
ATE7298T1 (de) Basisch substituierte 5-phenyltetrazole, verfahren zu ihrer herstellung und ihre verwendung als heilmittel.
ATE80629T1 (de) Beta-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln.
DK0725785T3 (da) Fremgangsmåde til fremstilling af rufloxacin af deraf
RU94046014A (ru) Диаминовые соли клавулановой кислоты

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0874855

Country of ref document: EP